Stock CORCEPT THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Corcept Therapeutics Nasdaq

Equities

Chart calendar Corcept Therapeutics

e85020e60c9.asfDUhDWFtOE0asaWTU8XJ1m8OypPfM5RqeKOw6medQ.C_CRIkKVf4z-gZhOaltQGdA5sr-ed5d2C8nHQUP2FLgFgY5jRe9vjN6wkw~a132a9fd2ff9608cd44cfa755d7106ce

Upcoming events on Corcept Therapeutics

2024-05-01 04:05 pm Q1 2024 Earnings Release
2024-05-01 05:00 pm Q1 2024 Earnings Call
2024-05-17 10:30 am Annual General Meeting
2024-07-30 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-11 Q4 2024 Earnings Release (Projected)
2025-04-29 Q1 2025 Earnings Release (Projected)

Past events on Corcept Therapeutics

2024-02-15 05:00 pm Q4 2023 Earnings Call
2024-02-15 04:05 pm Q4 2023 Earnings Release
2023-11-01 05:00 pm Q3 2023 Earnings Call
2023-11-01 04:05 pm Q3 2023 Earnings Release
2023-08-02 05:00 pm Q2 2023 Earnings Call
2023-08-02 04:05 pm Q2 2023 Earnings Release
2023-05-19 10:30 am Annual General Meeting
2023-05-03 05:00 pm Q1 2023 Earnings Call
2023-05-03 04:05 pm Q1 2023 Earnings Release
2023-03-15 Jefferies Biotech on the Bay Summit
2023-02-28 05:00 pm Q4 2022 Earnings Call
2023-02-28 04:05 pm Q4 2022 Earnings Release
2023-02-16 03:00 pm SVB Securities Global Biopharma Conference
2022-11-03 05:00 pm Q3 2022 Earnings Call
2022-11-03 04:05 pm Q3 2022 Earnings Release
2022-08-03 05:00 pm Interim 2022 Earnings Call
2022-08-03 04:05 pm Interim 2022 Earnings Release
2022-06-06 10:00 am American Society of Clinical Oncology Meeting
2022-05-31 10:30 am Annual General Meeting
2022-05-05 05:00 pm Q1 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		307
306
0.02%		354
358
-1.28%		366
368
-0.47%		402
404
-0.5%		482
476
1.28%
611

EBITDA
Million USD		Released
Forecast
Spread 		112
116
-3.02%		129
125
3.07%		126
149
-15.93%		156
160
-2.53%		0,00
102
-
137

EBIT
Million USD		Released
Forecast
Spread 		112
113
-1.51%		128
123
4.55%		124
131
-5.31%		113
140
-19.59%		107
109
-1.52%
132

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		117
118
-1.24%		132
127
3.29%		125
126
-0.53%		116
127
-8.79%		125
124
0.58%
142

Net income
Million USD		Released
Forecast
Spread 		94,2
96,8
-2.67%		106
101
4.74%		113
110
2.53%		101
114
-11.14%		105
104
1.27%
117

EPS
USD		Released
Forecast
Spread 		0,77
0,78
-1.28%		0,85
0,81
5.59%		0,89
0,86
3.29%		0,87
0,96
-8.9%		0,94
0,92
1.95%
1,02

Announcement Date20/02/2008/02/2115/02/2228/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		98,8
101
-1.74%		93,7
98,6
-4.98%		103
101
2.36%		102
108
-5.43%		103
105
-1.93%		106
105
0.71%		118
110
7.4%		124
120
3.24%		135
129
4.72%
141


151


156


163


154

EBITDA
Million USD		Released
Forecast
Spread 		37,0
51,3
-27.97%		37,8
45,0
-15.96%		42,2
43,8
-3.76%		42,7
42,5
0.43%		33,2
37,2
-10.74%		26,2
24,0
9.03%		29,8
19,3
54.24%




















EBIT
Million USD		Released
Forecast
Spread 		36,7
38,4
-4.45%		26,8
36,6
-26.84%		31,4
35,7
-11.93%		31,9
36,7
-12.91%		22,5
37,2
-39.47%		14,9
25,5
-41.71%		29,6
18,2
62.43%		31,2
26,9
15.77%		31,7
33,3
-4.94%
27,8


32,4


34,4


38,2


30,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		36,7
36,4
1.02%		26,8
35,7
-24.82%		32,1
32,4
-1.19%		33,0
33,4
-1.18%		24,3
35,5
-31.58%		18,4
24,9
-25.97%		32,9
19,7
66.88%		36,4
28,7
26.6%		36,8
36,1
1.97%
30,6


35,1


37,0


40,3


35,5

Net income
Million USD		Released
Forecast
Spread 		32,1
26,0
23.1%		22,8
28,3
-19.54%		27,4
26,1
4.95%		34,6
27,8
24.33%		16,6
29,2
-43.27%		15,8
21,1
-25.23%		27,4
17,2
59.26%		31,2
24,4
27.88%		31,1
29,6
5.25%
25,3


28,9


30,5


33,3


29,0

EPS
USD		Released
Forecast
Spread 		0,26
0,22
20.93%		0,20
0,23
-13.79%		0,24
0,21
12.15%		0,30
0,23
30.43%		0,14
0,23
-37.78%		0,14
0,19
-27.58%		0,25
0,15
66.67%		0,28
0,22
28.25%		0,28
0,26
8.53%
0,22


0,25


0,27


0,29


0,27

Announcement Date15/02/2205/05/2203/08/2203/11/2228/02/2303/05/2302/08/2301/11/2315/02/24-----

Upcoming sector events for Corcept Therapeutics

2024-04-26 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
2024-04-26 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
2024-04-26 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
2024-04-26 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
2024-04-26 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-26 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
2024-04-26 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
2024-04-26 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
2024-04-26 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
2024-04-26 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
More events

Past sector events for Corcept Therapeutics

Today PKU HEALTHCARE CORP.,LTD.: Q4 2023 Earnings Release
Today SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD: Q4 2023 Earnings Release
Today BEIJING KONRUNS PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today BEXIMCO PHARMACEUTICALS LIMITED: Q3 2024 Earnings Release (Projected)
Today TORII PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ABBVIE INC.: Q1 2024 Earnings Release
Today CHANGZHOU QIANHONG BIOPHARMA CO.,LTD: Q4 2023 Earnings Release
Today CHANGZHOU QIANHONG BIOPHARMA CO.,LTD: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CORT Stock
  4. Stock
  5. Calendar Corcept Therapeutics